Eledon Pharmaceuticals, Inc.ELDNNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank54
Studio
Year-over-Year Change

Free cash flow yield

Latest
-50.45%
↑ 72% vs avg
Percentile
P54
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-181.11%
Historical baseline
PeriodValueYoY Change
2025-50.45%-113.4%
2024-23.64%+73.5%
2023-89.20%-2.2%
2022-87.27%-97.3%
2021-44.24%+35.0%
2020-68.06%+66.4%
2019-202.48%-145.3%
2018-82.54%-4.9%
2017-78.67%+92.7%
2016-1084.53%-